AORT
Price:
$29.41
Market Cap:
$1.23B
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system fo...[Read more]
Industry
Medical - Devices
IPO Date
1993-02-12
Stock Exchange
NYSE
Ticker
AORT
According to Artivion, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.54B. This represents a change of 23.00% compared to the average of 1.25B of the last 4 quarters.
The mean historical Enterprise Value of Artivion, Inc. over the last ten years is 845.10M. The current 1.54B Enterprise Value has changed 18.12% with respect to the historical average. Over the past ten years (40 quarters), AORT's Enterprise Value was at its highest in in the September 2018 quarter at 1.43B. The Enterprise Value was at its lowest in in the September 2015 quarter at 232.22M.
Average
845.10M
Median
922.81M
Minimum
255.66M
Maximum
1.22B
Discovering the peaks and valleys of Artivion, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 144.17%
Maximum Annual Enterprise Value = 1.22B
Minimum Annual Increase = -27.05%
Minimum Annual Enterprise Value = 255.66M
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.03B | 28.06% |
2022 | 802.67M | -27.05% |
2021 | 1.10B | -4.26% |
2020 | 1.15B | -5.51% |
2019 | 1.22B | 3.09% |
2018 | 1.18B | 44.30% |
2017 | 817.74M | 30.99% |
2016 | 624.26M | 144.17% |
2015 | 255.66M | -7.65% |
2014 | 276.83M | 8.49% |
The current Enterprise Value of Artivion, Inc. (AORT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
976.96M
5-year avg
1.06B
10-year avg
845.10M
Artivion, Inc.’s Enterprise Value is greater than Anika Therapeutics, Inc. (217.36M), greater than Sight Sciences, Inc. (115.68M), greater than Orthofix Medical Inc. (836.31M), greater than Avanos Medical, Inc. (993.74M), greater than AxoGen, Inc. (677.76M), greater than Pulmonx Corporation (264.57M), greater than Electromed, Inc. (241.99M), greater than Surmodics, Inc. (559.24M), less than NuVasive, Inc. (2.84B), less than CONMED Corporation (3.23B), greater than OrthoPediatrics Corp. (608.01M), greater than SI-BONE, Inc. (555.40M), greater than NeuroPace, Inc. (415.96M), greater than CVRx, Inc. (318.84M), greater than Heska Corporation (1.26B), less than Integer Holdings Corporation (5.84B), greater than Treace Medical Concepts, Inc. (590.65M), greater than Establishment Labs Holdings Inc. (1.24B),
Company | Enterprise Value | Market cap |
---|---|---|
217.36M | $252.20M | |
115.68M | $198.96M | |
836.31M | $729.13M | |
993.74M | $880.54M | |
677.76M | $627.56M | |
264.57M | $272.07M | |
241.99M | $255.85M | |
559.24M | $565.81M | |
2.84B | $2.08B | |
3.23B | $2.33B | |
608.01M | $634.46M | |
555.40M | $547.08M | |
415.96M | $357.88M | |
318.84M | $368.57M | |
1.26B | $1.31B | |
5.84B | $4.71B | |
590.65M | $532.64M | |
1.24B | $1.27B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Artivion, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Artivion, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Artivion, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Artivion, Inc. (AORT)?
What is the 3-year average Enterprise Value for Artivion, Inc. (AORT)?
What is the 5-year average Enterprise Value for Artivion, Inc. (AORT)?
How does the current Enterprise Value for Artivion, Inc. (AORT) compare to its historical average?